Kailera Kailera
  • About
  • Science
  • Programs
  • Team
  • News
  • Contact
  • Join Us
Select Page

Efficacy and Safety of HRS9531, a Novel Dual GLP-1/GIP Receptor agonist, in Patients with Type 2 Diabetes Mellitus (T2DM): A Phase 2 Trial

by Siro Solutions Dev | Sep 9, 2024

  • Privacy Policy
  • Terms of Use
©2025 Kailera Therapeutics.

Website by 22 Fillmore

©2025 Kailera Therapeutics.
  • Privacy Policy
  • Terms of Use

Website by 22 Fillmore